Brief: Dermapharm Holding H1 Adjusted EBITDA Up 50% To EUR 137 Million

Dermapharm Holding SE

07/09/2021 06:35

Sept 7 (Reuters) - Dermapharm Holding SE  DMPG.DE :
    * DERMAPHARM HOLDING SE PUBLISHES H1 2021 REPORT,  CONFIRMS
OUTLOOK FOR 2021 OVERALL
    * OUTLOOK FOR 2021 CONFIRMED
    * H1 CONSOLIDATED REVENUE UP YEAR ON YEAR BY 13% TO EUR 428
MILLION
    * H1 ADJUSTED CONSOLIDATED EBITDA UP APPROXIMATELY 50% YEAR
ON
YEAR AT EUR 137 MILLION
    * H1 ADJUSTED CONSOLIDATED EBITDA MARGIN IMPROVES TO 32.0%

Source text for Eikon:  ID:nEQ7B2QN6a 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))